07:00 , Jun 16, 2014 |  BC Week In Review  |  Company News

B. Braun Melsungen, CeGaT deal

CeGaT and B. Braun's B. Braun Medical Inc. U.S. subsidiary established JV B. Braun CeGaT LLC to market CeGaT's diagnostic panels in the U.S. The newco will be based at B. Braun Medical's headquarters in...
08:00 , Dec 13, 2010 |  BC Week In Review  |  Company News

Abbott, B. Braun Melsungen AG, Boehringer Ingelheim pharmaceuticals news

The U.S. Department of Justice reached settlements with three companies to resolve allegations made under the False Claims Act that the companies reported false and inflated prices for numerous products to federal health care programs....
01:09 , Dec 8, 2010 |  BC Extra  |  Company News

Three companies settle false claims allegations

The U.S. Department of Justice reached settlements with three companies to resolve allegations that the companies reported false and inflated prices for numerous products to federal health care programs. Boehringer Ingelheim GmbH (Ingelheim, Germany) paid...
07:00 , Aug 25, 2003 |  BC Week In Review  |  Company News

Advanced Medical Solutions, B. Braun Melsungen AG sales and marketing update

AMS will supply alginate natural seaweed-derived polymer to the B. Braun division B. Braun Hospicare. B. Braun will package and distribute the wound healing product under its Askina Sorb brand. Advanced Medical Solutions (LSE:AMS), Winsford,...
07:00 , Oct 6, 1997 |  BC Week In Review  |  Company News

Genzyme Transgenics, B. Braun Melsungen AG deal

The companies will develop and market a transgenically produced form of an undisclosed recombinant product. GZTC will express the protein in the milk of transgenic goats, produce clinical grade material and conduct preclinical and initial...